CD4+CD25+ suppressor T cells: More questions than answers

Nature Reviews Immunology

Volumn 2, Issue 6, 2002, Pages 389-400

  Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN; ABATACEPT; ANTIBODY CONJUGATE; CYTOKINE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; ENTERITIS; GASTRITIS; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCID MOUSE; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; RAT; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MODELS, IMMUNOLOGICAL; RATS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036597371     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri821     Document Type: Review

References (85)

1. Gershon, R. K. & Kondo, K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-735 (1970).
2. Gershon, R. K. & Kondo, K. Infectious immunological tolerance. Immunology 21, 903-914 (1971).
3. Moller, G. Do suppressor T cells exist? Scand. J. Immunol. 27, 247-250 (1988).
4. Green, D. R. & Webb, D. R. Saying the 'S' word in public. Immunol. Today 14, 523-525 (1993).
5. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains. J. Immunol. 155, 1151-1164 (1995). The first paper to show that CD25 can be used as a marker for suppressor T cells.
6. Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
7. + T cells.
8. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
9. low T cells: a population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 28, 3435-3447 (1998).
10. + T cells suppress naive and memory T-cell proliferation and can be expanded in vitro without loss of suppressor function. J. Exp. Med. 193, 1295-1302 (2001).
11. + T cells with regulatory properties from human blood. J. Exp. Med. 193, 1303-1310 (2001).
12. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-1294 (2001).
13. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31, 1122-1131 (2001).
14. + thymocytes and peripheral T cells have immune suppressive activity. Eur. J. Immunol. 31, 1247-1254 (2001).
15. + cells: a naturally occurring population of regulatory T cells. Blood 98, 2736-2744 (2001).
16. + regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253 (2001).
17. Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A. & Weiner, H. L. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994).
18. Shevach, E. M. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18, 423-449 (2000).
19. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455-458 (2001).
20. Maloy, K. J. & Powrie, F. Regulatory T cells in the control of immune pathology. Nature Immunol. 2, 816-822 (2001).
21. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 182-190 (2000).
22. + regulatory T cells constitutively expressing cytotoxic lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-309 (2000).
23. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
24. + regulatory T cells is mediated by cell-surface-bound transforming growth factor-β. J. Exp. Med. 194, 629-644 (2001).
25. Letterio, J. J. & Roberts, A. B. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137-161 (1998).
26. Yang, X. et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T-cell responsiveness to TGF-β. EMBO J. 18, 1280-1291 (1999).
27. Lucas, P. J., Kim, S. J., Melby, S. J. & Gress, R. E. Disruption of T-cell homeostasis in mice expressing a T-cell-specific dominant-negative transforming growth factor-βII receptor. J. Exp. Med. 191, 1187-1196 (2000).
28. Kulkarni, A. B. et al. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA 93, 770-774 (1993).
29. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543 (2000).
30. + immunoregulatory cells. J. Immunol. 167, 1137-1140 (2001).
31. + T cells. Nature Med. 4, 1377-1382 (1998).
32. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
33. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135-142 (2002).
34. Sinclair, N. R. S. Immunoreceptor tyrosine-based inhibitory motifs on activating molecules. Crit. Rev. Immunol. 20, 89-102 (2000).
35. Burshtyn, D. N. & Long, E. O. Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell Biol. 7, 473-479 (1997).
36. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powne, F. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1003 (1999).
37. + T cells. Microbes Infect. 3, 919-927 (2001).
38. + thymocytes. J. Exp. Med. 189, 279-288 (1999).
39. + T cells. J. Autoimmun. 16, 115-123 (2001).
40. Grande, J. P. Role of transforming growth factor-β in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 214, 27-40 (1997).
41. Stockinger, B., Barthlott, T. & Kassiotis, G. T-cell regulation: a special job or everyone's responsibility? Nature Immunol. 2, 757-758 (2001).
42. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1211-1218 (1998).
43. Bonomo, A., Kehn, P. J. & Shevach, E. M. Post-thymectomy autoimmunity-abnormal T-cell homeostasis. Immunol. Today 16, 61-67 (1995).
44. Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2R α-chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371-378 (1997).
45. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326 (1999).
46. + regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301-306 (2001).
47. + T cells can be selected on thymic cortical epithelium.
48. Laufer, T. M. et al. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383, 81-85 (1996).
49. Malek, T. R., Porter B. O., Codias, E. K., Scibelli, P. & Yu, A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164, 2905-2914 (2000).
50. Kagami, S.-I. et al. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood 97, 2358-2365 (2001).
51. Suzuki, H., Zhou, Y. W., Kato, M., Mak, T. W. & Nakashima, I. Normal regulatory αβ T cells effectively eliminate abnormally activated T cells lacking the interleukin-2 receptor-β in vivo. J. Exp. Med. 190, 1561-1571 (1999).
52. Kumanogoh, A. et al. Increased T-cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 regulatory T-cell development. J. Immunol. 168, 353-360 (2001).
53. + T cells have a role in regulating diabetes in NOD mice.
54. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31, 1637-1645 (2001).
55. Taguchi, O. & Nishizuka, Y. Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self-tolerance. J. Exp. Med. 165, 146-156 (1987).
56. Taguchi, O. et al. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 82, 365-369 (1994).
57. McCullagh, P. The significance of immune suppression in normal self tolerance. Immunol. Rev. 149, 127-154 (1996).
58. Seddon, B. & Mason, D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189, 877-881 (1999). The most convincing study to show that regulatory T cells recognize organ-specific antigens.
59. Garza, K. M., Agersborg, S. S., Baker, E. & Tung, K. S. T. Persistence of physiological antigen is required for the regulation of self-tolerance. J. Immunol. 164, 3982-3989 (2000).
60. McHugh, R. S., Shevach, E. M., Margulies, D. H. & Natarajan, K. A T-cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur. J. Immunol. 31, 2094-2103 (2001).
61. + regulatory T cells. J. Exp. Med. 194, 847-853 (2001).
62. Bystry, R. S. et al. B cells and professional APCs recruit regulatory T cells via CCL4. Nature Immunol. 2, 1126-1152 (2001).
63. + T cells expressing endogenous T-cell receptor chains protect myelin basic protein-specific transgenic mice from spontanteous autoimmune encephalomyelitis. J. Exp. Med. 188, 1883-1894 (1998).
64. + T cells that prevent spontaneous autoimmune encephalomyelitis. J. Immunol. 164, 5499-5507 (2000).
65. Annacker, O., Buden-Defranoux, O., Pimenta-Araujo, R., Cumano, A. & Bandeira, A. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T-cell compartment. J. Immunol. 164, 3573-3580 (2000).
66. + subpopulations. J. Immunol. 165, 3105-3110 (2000).
67. R1 population of regulatory T cells.
68. Levings, M. K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530-5539 (2001).
69. + T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
70. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. & Bhardwaj, N. Antigen-specific inhibition of effector T-cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238 (2001).
71. + regulatory T cells from human peripheral blood. J. Immunol. 166, 7282-7289 (2001).
72. Gregori, S. et al. Regulatory T cells induced by 1α ,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945-1953 (2001).
73. Allison, A. C. & Eugui, E. M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin. Transplant. 10, 77-84 (1996).
74. Mehling, A. et al. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol. 165, 2374-2381 (2000).
75. Hara, M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796 (2001).
76. + suppressor T cells. J. Exp. Med. 193, F41-F45 (2001).
77. Vendetti, S. et al. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J. Immunol. 165, 1175-1181 (2000).
78. Taams, L. S., Boot, E. P. J., van Eden, W. & Wauben, M. H. M. 'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells. J. Autoimmun. 14, 335-341 (2000).
79. Thorstenson, K. M. & Khoruts, A. Generation of anergic and potentially immunoregulatory CD25-CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167, 188-195 (2001).
80. Onizuka, S. et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor-α) monoclonal antibody. Cancer Res. 59, 3128-3133 (1999).
81. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211-5218 (1999).
82. + T cells in preventing the Induction of tumour immunity that is independent of CTLA4.
83. Bloom, B. R., Modlin, R. L. & Salgame, P. Stigma variations: observations on suppressor T cells and leprosy. Annu. Rev. Immunol. 10, 453-488 (1992).
84. Belkaid, Y. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506 (2001).
85. + regulatory T cells is necessary, but not sufficient, for the induction of organ-specific autoimmune disease. J. Immunol. (in the press).